FindTrial
Sign In

COVID-19 Contact Vaccine Study

COVID-19 Contact Vaccine Study - CoCoVac

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023972
Enrollment
1000
Registered
2020-12-30
Start date
2021-01-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 U07.1

Interventions

Group 1: Analysis of immunity before and after natural infection or vaccination.

Sponsors

Medizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: natural infection or vaccination

Exclusion criteria

Exclusion criteria: no informed consent

Design outcomes

Primary

MeasureTime frame
Immunity (Anti-SARS-CoV-2 IgG) month 0, 1, 3, 6, 12.—

Secondary

MeasureTime frame
side effects/symptoms—

Countries

Germany

Contacts

Public ContactAlexandra Jablonka

Medizinische Hochschule Hannover

jablonka.alexandra@mh-hannover.de0511 532 5337

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026